Dr. DEEKSHA THORAT

Dr. MEHUL SHAH, Dr. SHREYA SHAH, Dr. RUHI GUNAY

Abstract

INTRODUCTION: BRVO IS AN IMPORTANT CAUSE OF MONOCULAR BLINDNES SO WE THE STUDIED EFFECT OF TREATMENT ON ITS VISUAL OUTCOME.

METHOD: THIS IS A RETROSPECTIVE ANALYSIS OF A COHORT DURING LAST FIVE YEARS AT TERTIARY EYE CARE CENTER. ALL EYES WERE TREATED WITH MEDICAL AND LASER THERAPY. WE CREATED AND FORMAT AND RETRIEVED DATA FROM OUR EMR. DESCRIPTIVE AND CROSS TABULATION METHOD USED FOR ANALYSES. P VALUE <0.05 CONSIDERED STASTICALLY SIGNIFICANT. RESULT: OUR COHORT INCLUDED 155 EYES OF 152 PATIENTS OUT OF WHICH 53.3%, 46.7% M:F,MEAN AGE 57.4 YEARS, 45.4 % RE, 52.6 % LE AND 2% BE.ON PRESENTATION 40.1% HAD VISION >6/24 AND 41.1 % HAD VISION < 3/60. POST TREATMENT VISION ON SUBSEQUENT VISITS >6/24 IN 32.5% AND <3/60 IN 21.8% CASES. DURING FINAL VISIT VISION >6/24 AND <3/60 IN 16.6, 3.3% RESPECTIVELY. THERE WAS A SIGNIFICANT DIFFERENCE OF VISION BETWEEN SECOND AND FINAL VISIT COMPARED TO THE FIRST VISIT. CONCLUSION: MEDICAL AND LASER TREATMENT OF BRVO HAS A SIGNIFICANT IMPACT ON VISION. [advanced_iframe src="https://view.officeapps.live.com/op/embed.aspx?src=https://aiosproceedings.s3.ap-southeast-1.amazonaws.com/2021/E-Poster/FP369.pptx" width="100%" height="608"]